CBTRUS - Year 2002 Statistical Tables and Figures

Year 2002 Statistical Tables and Figures

Table 1 CBTRUS Brain and Central Nervous System Tumor Histology Groupings, 2002 Revision

Table 2 Annual Populations Averaged over 1995-1999 for CBTRUS, 12 States Combined, by Age, Gender and Race

Table 3 1998 Annual Populations for CBTRUS, 15 States Combined, by Age, Gender and Hispanic Origin^a

Table 4 2000 U.S. Standard Population

Table 5 Characteristics of Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumors^a in Participating Registries, CBTRUS 1995-1999

Table 6 Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Incidence Rates^a,b by Age, State, and Behavior, Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS 1995-1999^c

Table 7 Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Incidence Rates^a by Site^b and Gender, Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS 1995-1999^c

Table 8 Distribution and Incidence Rates^a of Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumors by Major Histology Groupings and Histology, Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS 1995-1999^b

Table 9 Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Incidence Rates^a by Major Histology Groupings, Histology and Gender, Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS 1995-1999^b

Table 10 Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Incidence Rates^a by Major Histology Groupings, Histology and Race, Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS 1995-1999^b

Table 11 Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Incidence Rates^a by Major Histology Groupings, Histology and Hispanic Ethnicity, Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS 1998, 15 Registries^b
Table 12 Selected Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Age-Specific Incidence Rates^a by Age at Diagnosis, CBTRUS 1995-1999^b
Table 13 Selected Childhood Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Incidence Rates^a by Major Histology Groupings, Histology and Gender (Ages 0-19), Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS 1995-1999^b

Table 14 Childhood Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Incidence Rates^a by Major Histology Groupings and Race (Ages 0-19), Age-Adjusted to the 2000 U.S. Standard Population, CBTRUS 1995-1999^b

Table 15 Selected Childhood Primary (Malignant and Non-Malignant) Brain and Central Nervous System Tumor Age-Specific Incidence Rates^a(Ages 0-19), by Age at Diagnosis, CBTRUS 1995-1999^b

Table 16 Primary Malignant Brain and Other Nervous System Tumor Incidence and Mortality Rates^a by State, Age-Adjusted to the 2000 U.S Standard Population^b

Table 17 Primary Brain and Other Nervous System Tumors, Estimated Number of Cases^a,b by State, 2002; Primary Malignant Brain and Other Nervous System Tumors, Estimated Number of Cases^a,b and Deaths ^c,d by State, 2002

Table 18 Five-Year Relative Survival Rates For Malignant Brain and Central Nervous System Tumors By Site^a And Gender, SEER 1973-1999

Table 19 One-, Two-, Five-, And Ten-Year Observed And Relative Survival Rates^a For Selected Malignant Brain and Central Nervous System Tumors, SEER 1973-1999

Table 20 One-, Two-, Five-, And Ten-Year Relative Survival Rates^a For Selected Malignant Brain and Central Nervous System Tumors By Age Groups, SEER 1973-1999

Disclaimer
The Central Brain Tumor Registry of the United States (CBTRUS) is a not-for-profit corporation which gathers and disseminates epidemiologic data on primary brain tumors in order to facilitate research and establish awareness of the disease. CBTRUS makes no representations or warranties, and gives no other assurances or guarantees, express or implied, with respect to the accuracy or completeness of the data presented. The information provided in this website is not intended to assist in the evaluation, diagnosis or treatment of individual diseases. Persons with questions regarding individual diseases should contact their own physician to obtain medical assistance.